Saturday Series

We're back. Let's talk about the canary in the mine regarding 2024!

ASX biotechs jumped 12.5% in a month, and biotech is the canary in the coal mine for investor risk appetite. How to build your own watchlist of bellwether stocks to track the ripple effect.

Ben Williamson

18 January 2024 · 3 min read

The early weeks of January are usually pretty slow in the market.

But there's something a bit different about 2024. There is a sense of... dare I say it... optimism?

Let's discuss.

Keep reading for free

Subscribe to the newsletter and Ben Williamson will send every new article to your inbox. This one unlocks instantly.

Keep reading

Saturday Series

When there's no multiple, they're backing you

If you're high-growth, R&D-heavy or an explorer, there is no easy multiple for the market to anchor to. Investors are backing two things instead: a story they can understand, and a team they can see.

Ben Williamson · 9 July 2026

Saturday Series

Stop being such a Jorc!

Most of your investors are not professionals in your field, and if you only speak to the ones who already understand you, you're ignoring 99% of the public. The two answers to closing the gap between where you are and how you're priced: education and trust.

Ben Williamson · 2 July 2026

Saturday Series

Does your share price reflect reality?

Your work today won't turn into reported results for months, so the market often prices where you were, not where you are. A prompt to think about how big that gap is for your company, and how you communicate it.

Ben Williamson · 26 June 2026